BioSpace News Archive

With one internet search, a patient can find a host of information and marketing materials touting the purported benefits of laser surgery.

Medison Biotech (1995) Ltd. (“Medison”), which together with its affiliates owns more than 10.4 million shares or 7.5% of Knight Therapeutics, Inc. (TSX:GUD) (“Knight” or the “Company”), today commented on the recent claims brought against various pharma companies in the United States and Canada (including against Joddes and Pharmascience, the Goodman family businesses in which Jonathan Goodman, Knight’s CEO, personally owns at least a 25% interest).

Healthy Directions LLC, a subsidiary of Adaptive Health, LLC, is proud to announce its newly signed partnership with Dr. Briana Sinatra, a practicing, board-certified naturopathic physician with a focus on women’s and family health and wellness.

As the single largest purchaser of goods and services, the federal government is using procurement to help Canadian small businesses succeed.

MedCerts, an education provider of next-generation online career and certification training, launched a Patient Care Technician program adding to their growing list of over 40 programs

To address an urgent shortage of healthcare professionals needed to navigate an increasingly complex healthcare system, Western Governors University (WGU) is now offering a first-of-its-kind Bachelor of Science Health Services Coordination (BSHSC) degree program.

HumanN, an industry leader in functional food and nutritional supplements for whole body health, has been ranked as one of the fastest growing private companies in America for the fifth consecutive year.

A recent Gallup poll reveals what too many Americans already know to be true: healthcare is becoming less and less affordable.

Illinois Bone & Joint Institute (IBJI), one of the largest independent, physician-owned orthopedic practices in the United States, is excited to welcome Sheela Metgud, MD, fellowship-trained rheumatologist.

Verastem, Inc. (Nasdaq: VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced that the Company will present at the 21st Annual H.C. Wainwright Global Investment Conference on Tuesday,